Libbs Farmacêutica Ltda.
🇧🇷Brazil
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1958-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.libbs.com.br
Real World Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie
Not yet recruiting
- Conditions
- Metastatic Colorectal Cancer
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Libbs Farmacêutica LTDA
- Target Recruit Count
- 133
- Registration Number
- NCT06808685
Evaluation of Knowledge and Practice About Prostate Cancer in Male Employees
Completed
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: questionare online application
- First Posted Date
- 2021-09-10
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Libbs Farmacêutica LTDA
- Target Recruit Count
- 280
- Registration Number
- NCT05040672
- Locations
- 🇧🇷
Augusto Figueiredo, São Paulo, Brazil
Study for Late Assessment of the Safety and Efficacy of Biosimilar Rituximab
Completed
- Conditions
- Diffuse Large B Cell Lymphoma
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2023-10-12
- Lead Sponsor
- Libbs Farmacêutica LTDA
- Target Recruit Count
- 27
- Registration Number
- NCT04928573
- Locations
- 🇧🇷
Dr Fernando Pericole, Campinas, São Paulo, Brazil
Prevalence of Self-reported Premenstrual Syndrome and Analysis of Somatic and Psychoemotional Symptoms
Completed
- Conditions
- Premenstrual Syndrome
- First Posted Date
- 2020-07-02
- Last Posted Date
- 2020-07-02
- Lead Sponsor
- Libbs Farmacêutica LTDA
- Target Recruit Count
- 1022
- Registration Number
- NCT04455685
- Locations
- 🇧🇷
Augusto Theodoro de Figueiredo, São Paulo, Brazil
Assessment of Lifestyle, Blood Pressure, Cholesterol and Glycated Hemoglobin in a Specific Population
Completed
- Conditions
- Arterial HypertensionBlood Glucose, HighCholesterol; Lipidosis
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- Libbs Farmacêutica LTDA
- Target Recruit Count
- 2472
- Registration Number
- NCT04373863
- Locations
- 🇧🇷
Augusto Theodoro de Figueiredo, São Paulo, Brazil
Acceptability, Under Use in Real Conditions Of Two Vaginal Moistures Indicated for Women With Vaginal Drying
Not Applicable
Completed
- Conditions
- Vaginal Dryness
- Interventions
- Other: Belamy (vaginal moisturizer)
- First Posted Date
- 2020-04-13
- Last Posted Date
- 2020-04-13
- Lead Sponsor
- Libbs Farmacêutica LTDA
- Target Recruit Count
- 74
- Registration Number
- NCT04342559
- Locations
- 🇧🇷
Augusto Theodoro de Figueiredo, São Paulo, Brazil
Topical Nasal Fluticasone Propionate in the Control of Allergic Rhinitis SymptomsPerene
- First Posted Date
- 2020-04-03
- Last Posted Date
- 2020-04-08
- Lead Sponsor
- Libbs Farmacêutica LTDA
- Target Recruit Count
- 566
- Registration Number
- NCT04332978
Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone Furoates
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- Libbs Farmacêutica LTDA
- Target Recruit Count
- 32
- Registration Number
- NCT04271007
- Locations
- 🇧🇷
Dr Sérgio Sckalka, Osasco, São Paulo, Brazil
Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer
Active, not recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2019-03-27
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Libbs Farmacêutica LTDA
- Target Recruit Count
- 170
- Registration Number
- NCT03892655
- Locations
- 🇧🇷
Ruffo de Freitas Junior, Goiânia, Goiás, Brazil
🇧🇷Kaique Almeida, São Paulo, Brazil
🇧🇷Mariana Scaranti, São Paulo, Brazil
© Copyright 2025. All Rights Reserved by MedPath